Xabier Agirre

Navarre Institute of Health Research — Spain

Biochemistry, Genetics and Molecular Biology · Life Sciences

60h-index11.6kcitations278works9.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(67), Protein Degradation and Inhibitors(49), Multiple Myeloma Research and Treatments(42), Histone Deacetylase Inhibitors Research(41), Cancer-related gene regulation(40)

Publications278 total

Beyond synthetic lethality in large-scale metabolic and regulatory network models via genetic minimal intervention set
Bioinformatics Advances·2025Open Access
Beyond synthetic lethality in large-scale metabolic and regulatory network models via genetic minimal intervention sets
2025Open Access
Reprogramming glutamine metabolism enhances <i>BCMA</i> -CAR T-cell fitness and therapeutic efficacy in multiple myeloma
Blood·2025· 5 citedOpen Access
“Linc-ing” RNA isoforms to function in multiple myeloma
Blood·2025
Aptameroak Mieloma Anizkoitzaren aurkako RNA-n oinarritutako terapien garapenerako
IkerGazte Nazioarteko ikerketa euskaraz·2025Open Access
P-08.01 A combinatorial therapy for bladder cancer: epigenetic inhibitor and CAR-NK cells
Poster presentations·2025Open Access
Mapping Disease Transitions from Premalignant, Asymptomatic to Advanced Myeloma through Integrative Epigenomic and Transcriptional Analyses
Blood·2024
An IFNγ-Mediated Immune Inflamed Microenvironment State in Multiple Myeloma with TP53 Loss That Can be Therapeutically Exploited
Blood·2024· 3 citedOpen Access
G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1
Cell Death and Disease·2024· 10 citedOpen Access
An automated network-based tool to search for metabolic vulnerabilities in cancer
Nature Communications·2024· 7 citedOpen Access
BET inhibitors down-regulate the expression of the essential lncRNA &lt;i&gt;SMILO&lt;/i&gt; in multiple myeloma through regulation of the transcription factor FLI1
Haematologica·2024Open Access
RNA-loaded nanoparticles for the treatment of hematological cancers
Advanced Drug Delivery Reviews·2024· 10 citedOpen Access
P-262 Metabolism-Associated Genes As Biomarkers and Potential Therapeutic Targets for Hyperdiploid Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia·2024
P-250 Alteration of the m6A Regulatory Genes, With the Special Implication of Virma, Is Crucial for Multiple Myeloma Development
Clinical Lymphoma Myeloma & Leukemia·2024
Single-Nucleotide Polymorphisms in WNT Genes in Patients with Non-Syndromic Orofacial Clefts in a Polish Population
Diagnostics·2024· 3 citedOpen Access
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
Nature Communications·2024· 7 citedOpen Access
Stromal and Endothelial Transcriptional Changes during Progression from MGUS to Myeloma and after Treatment Response
2024· 5 citedOpen Access
HDACi vorinostat protects muscle from degeneration after acute rotator cuff injury in mice
Bone and Joint Research·2024· 3 citedOpen Access
An atlas of cells in the human tonsil
Immunity·2024· 130 citedOpen Access
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer
Cell Death Discovery·2024· 11 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Felipe Prósper(46), José Román‐Gómez(20), José I. Martı́n-Subero(16), Antonio Jiménez‐Velasco(15), Edurne San José‐Eneriz(15), Marı́a José Calasanz(15), Leire Gárate(14), Anabel Heiniger(14), António Torres(14), Reiner Siebert(11), Lucía Cordeu(10), Amaia Vilas‐Zornoza(9), Marta Gut(8), José A. Martínez-Climent(7), Germán Navarro(7), Marta Kulis(6), Bruno Paiva(6), Elı́as Campo(6), Juan A. Castillejo(6), Eva Bandrés(5)